跳至主要内容
临床试验/NCT05881252
NCT05881252已完成不适用

An Observational Study of Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 1,003 人开始时间: 2023年5月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,003
试验地点
1
主要终点
Number of patients with Congestive Heart Failure/Pulmonary Edema, hemorrhagic or ischemic Stroke, Acute Kidney Injury (creatinine > 1.5mg/dL), and/or or Myocardial Ischemia.

研究概览

简要总结

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is >= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of >= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (>= 180 SBP).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • any individual > 20 weeks' gestation in triage or admitted at Children's Memorial Hermann Hospital (CMHH) and with blood pressure with >= 160/110 mmHg

排除标准

  • Active seizure, stroke, Congestive Heart Failure (CHF)/pulmonary edema, acute kidney injury (AKI), or myocardial infarction (MI)
  • A history of stroke, CHF, chronic kidney disease (CKD), MI
  • Have Hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome or thrombocytopenia (platelets < 100×10^9/L)
  • Persistent neurologic symptoms including headache >8/10 one hour after analgesic or blurry vision/loss of vision

结局指标

主要结局

Number of patients with Congestive Heart Failure/Pulmonary Edema, hemorrhagic or ischemic Stroke, Acute Kidney Injury (creatinine > 1.5mg/dL), and/or or Myocardial Ischemia.

时间窗: during the time of delivery hospitalization (about 2 days to 3 months)

The primary outcome is a composite outcome, and will be reported as number of patients who have Congestive Heart Failure/Pulmonary Edema, hemorrhagic or ischemic Stroke, Acute Kidney Injury (creatinine \> 1.5mg/dL), and/or Myocardial Ischemia.

次要结局

  • Number of patients with posterior reversible encephalopathy syndrome (PRES)(during the time of delivery hospitalization (about 2 days to 3 months))
  • Number of patients with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome(during the time of delivery hospitalization (about 2 days to 3 months))
  • Number of patients with non-reassuring fetal heart rate tracing (NR-FHRT) requiring caesarean delivery(at the time of delivery)
  • Number of patients with Apgar score < 7 at 5 min(5 minutes after birth)
  • Number of patients with placental abruption(during the time of delivery hospitalization (about 2 days to 3 months))
  • Number of patients with eclampsia(during the time of delivery hospitalization (about 2 days to 3 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristen Cagino

Fellow

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验